Technological Advances in the Diagnosis of Cardiovascular Disease: A Public Health Strategy
-
Published:2024-08-16
Issue:8
Volume:21
Page:1083
-
ISSN:1660-4601
-
Container-title:International Journal of Environmental Research and Public Health
-
language:en
-
Short-container-title:IJERPH
Author:
Restrepo Tique Maria1, Araque Oscar1ORCID, Sanchez-Echeverri Luz Adriana2ORCID
Affiliation:
1. Facultad de Ingeniería, Universidad de Ibagué, Carrera 22 Calle 67, Ibagué 730002, Colombia 2. Facultad de Ciencias Naturales y Matemáticas, Universidad de Ibagué, Carrera 22 Calle 67, Ibagué 730002, Colombia
Abstract
This article reviews technological advances and global trends in the diagnosis, treatment, and monitoring of cardiovascular diseases. A bibliometric analysis was conducted using the SCOPUS database, following PRISMA-ScR guidelines, to identify relevant publications on technologies applied in the diagnosis and treatment of cardiovascular diseases. An increase in scientific output since 2018 was observed, reflecting a growing interest in the technologies available for the treatment of cardiovascular diseases, with terms such as “telemedicine”, “artificial intelligence”, “image analysis”, and “cardiovascular disease” standing out as some of the most commonly used terms in reference to CVDs. Significant trends were identified, such as the use of artificial intelligence in precision medicine and machine learning algorithms to analyse data and predict cardiovascular risk, as well as advances in image analysis and 3D printing. Highlighting the role of artificial intelligence in the diagnosis and continuous monitoring of cardiovascular diseases, showing its potential to improve prognosis and reduce the incidence of acute cardiovascular events, this study presents the integration of traditional cardiology methods with digital health technologies—through a transdisciplinary approach—as a new direction in cardiovascular health, emphasising individualised care and improved clinical outcomes. These advances have great potential to impact healthcare, and as this field expands, it is crucial to understand the current research landscape and direction in order to take advantage of each technological advancement for improving the diagnosis, treatment, and quality of life of cardiovascular patients. It is concluded that the integration of these technologies into clinical practice has important implications for public health. Early detection and personalised treatment of cardiovascular diseases (CVDs) can significantly reduce the morbidity and mortality associated with these diseases. In addition, the optimisation of public health resources through telemedicine and telecare can improve access to quality care. The implementation of these technologies can be a crucial step towards reducing the global burden of cardiovascular diseases.
Funder
Ministerio de Ciencia, Tecnología e Innovación Ministry of Science, Minciencias Biodiseño: “Una Oportunidad para Mejorar el Manejo de la Enfermedad Cardiovascular en el Tolima”
Reference39 articles.
1. Cardiovascular Diseases (CVDs) in COVID-19 Pandemic Era;Gerc;Mater. Socio-Medica,2020 2. Factores de riesgo cardiovascular;Med. -Programa de Form. Médica Contin. Acreditado,2005 3. Enfermedades no transmisibles. Tendencias actuales;Padua;Revista Cubana de Salud y Trabajo,2012 4. Turcu, A.M., Ilie, A.C., Ștefăniu, R., Țăranu, S.M., Sandu, I.A., Alexa-Stratulat, T., Pîslaru, A.I., and Alexa, I.D. (2023). The impact of heart rate variability monitoring on preventing severe cardiovascular events. Diagnostics, 13. 5. Blanco-Colio, L.M., Méndez-Barbero, N., Pello Lázaro, A.M., Aceña, Á., Tarín, N., Cristóbal, C., Martínez-Milla, J., González-Lorenzo, Ó., Martín-Ventura, J.L., and Huelmos, A. (2021). MCP-1 predicts recurrent cardiovascular events in patients with persistent inflammation. J. Clin. Med., 10.
|
|